The neural correlates of cognitive behavioral therapy: Recent progress in the investigation of patients with panic disorder

Behaviour Research and Therapy

Volumn 62, Issue , 2014, Pages 88-96

  Yang, Yunbo ^a   Kircher, Tilo ^a   Straube, Benjamin ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Exposure based cognitive behavior therapy; FMRI; Mechanism of action; Moderator; Neural correlates; Outcome prediction; Panic disorder with agoraphobia

Indexed keywords

AGORAPHOBIA; ARTICLE; BEHAVIOR THERAPY; COGNITIVE THERAPY; CONDITIONING; EXPOSURE THERAPY; FEAR CONDITIONING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC POLYMORPHISM; HAMILTON ANXIETY SCALE; HEREDITY; HUMAN; MULTICENTER STUDY (TOPIC); NERVE CELL NETWORK; NERVE FUNCTION; NEUROSCIENCE; PANIC; PERSONALIZED MEDICINE; PSYCHOTHERAPIST; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF CARE; THERAPY EFFECT; THERAPYGENETICS; TREATMENT OUTCOME; TREATMENT RESPONSE; VARIABLE NUMBER OF TANDEM REPEAT; BRAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANIC DISORDER; PATHOPHYSIOLOGY; PSYCHOLOGY;

AGORAPHOBIA; BRAIN; COGNITIVE THERAPY; HUMANS; IMPLOSIVE THERAPY; MAGNETIC RESONANCE IMAGING; PANIC DISORDER; TREATMENT OUTCOME;

EID: 84910033021     PISSN: 00057967     EISSN: 1873622X     Source Type: Journal    
DOI: 10.1016/j.brat.2014.07.011     Document Type: Article

References (72)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders (4th ed., text rev.) 2000, Author, Washington, DC.
2. Ball T.M., Stein M.B., Ramsawh H.J., Campbell-Sills L., Paulus M.P. Single-subject anxiety treatment outcome prediction using functional neuroimaging. Neuropsychopharmacology 2014, 39:1254-1261.
3. Barsaglini A., Sartori G., Benetti S., Pettersson-Yeo W., Mechelli A. The effects of psychotherapy on brain function: a systematic and critical review. Progress in Neurobiology 2014, 114C:1-14.
4. Beck A.T., Dozois D.J. Cognitive therapy: current status and future directions. Annual Review of Medicine 2011, 62:397-409.
5. Beevers C.G., McGeary J.E. Therapygenetics: moving towards personalized psychotherapy treatment. Trends in Cognitive Sciences 2012, 16:11-12.
6. Beutel M.E., Stark R., Pan H., Silbersweig D., Dietrich S. Changes of brain activation pre- post short-term psychodynamic inpatient psychotherapy: an fMRI study of panic disorder patients. Psychiatry Research: Neuroimaging 2010, 184:96-104.
7. Bishop S.J. Neural mechanisms underlying selective attention to threat. Annals of the New York Academy of Sciences 2008, 1129:141-152.
8. Blakemore S.J., Decety J. From the perception of action to the understanding of intention. Nature Reviews Neuroscience 2001, 2:561-567.
9. Bouton M.E., Mineka S., Barlow D.H. Amodern learning theory perspective on the etiology of panic disorder. Psychological Review 2001, 108:4-32.
10. Brandao M.L., Zanoveli J.M., Ruiz-Martinez R.C., Oliveira L.C., Landeira-Fernandez J. Different patterns of freezing behavior organized in the periaqueductal gray of rats: association with different types of anxiety. Behavioural Brain Research 2008, 188:1-13.
11. Butler A.C., Chapman J.E., Forman E.M., Beck A.T. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clinical Psychology Review 2006, 26:17-31.
12. Carrig M.M., Kolden G.G., Strauman T.J. Using functional magnetic resonance imaging in psychotherapy research: a brief introduction to concepts, methods, and task selection. Psychotherapy Research 2009, 19:409-417.
13. Clark D.A., Beck A.T. Cognitive theory and therapy of anxiety and depression: convergence with neurobiological findings. Trends in Cognitive Sciences 2010, 14:418-424.
14. Cuijpers P., Reynolds C.F., Donker T., Li J., Andersson G., Beekman A. Personalized treatment of adult depression: medication, psychotherapy, or both? A systematic review. Depression and Anxiety 2012, 29:855-864.
15. Deckert J., Catalano M., Syagailo Y.V., Bosi M., Okladnova O., Di Bella D., et al. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Human Molecular Genetics 1999, 8:621-624.
16. Delgado M.R., Nearing K.I., Ledoux J.E., Phelps E.A. Neural circuitry underlying the regulation of conditioned fear and its relation to extinction. Neuron 2008, 59:829-838.
17. Eisenberger N.I., Way B.M., Taylor S.E., Welch W.T., Lieberman M.D. Understanding genetic risk for aggression: clues from the brain's response to social exclusion. Biological Psychiatry 2007, 61:1100-1108.
18. Eley T.C., Hudson J.L., Creswell C., Tropeano M., Lester K.J., Cooper P., et al. Therapygenetics: the 5HTTLPR and response to psychological therapy. Molecular Psychiatry 2012, 17:236-237.
19. Etkin A., Egner T., Kalisch R. Emotional processing in anterior cingulate and medial prefrontal cortex. Trends in Cognitive Sciences 2011, 15:85-93.
20. Etkin A., Wager T.D. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. The American Journal of Psychiatry 2007, 164:1476-1488.
21. Friedman L., Glover G.H., Krenz D., Magnotta V., Birn F. Reducing inter-scanner variability of activation in a multicenter fMRI study: role of smoothness equalization. Neuroimage 2006, 32:1656-1668.
22. Gloster A.T., Wittchen H.U., Einsle F., Hofler M., Lang T., Helbig-Lang S., et al. Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia. European Archives of Psychiatry and Clinical Neuroscience 2009, 259:155-166.
23. Gloster A.T., Wittchen H.U., Einsle F., Lang T., Helbig-Lang S., Fydrich T., et al. Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT. Journal of Consulting and Clinical Psychology 2011, 79:406-420.
24. Gorman J.M., Kent J.M., Sullivan G.M., Coplan J.D. Neuroanatomical hypothesis of panic disorder, revised. The American Journal of Psychiatry 2000, 157:493-505.
25. Hahn, T., Kircher, T., Straube, B., Wittchen, H.-U., Konrad, C., Ströhle, A., etal. (in press). Predicting treatment response to cognitive-behavioral therapy in panic disorder with agoraphobia by integrating local neural information. JAMA Psychiatry.
26. Hahn T., Marquand A.F., Ehlis A.C., Dresler T., Kittel-Schneider S., Jarczok T.A., et al. Integrating neurobiological markers of depression. Archives of General Psychiatry 2011, 68:361-368.
27. Hofmann S.G. Cognitive processes during fear acquisition and extinction in animals and humans: implications for exposure therapy of anxiety disorders. Clinical Psychology Review 2008, 28:199-210.
28. Hofmann S.G., Asnaani A., Vonk I.J., Sawyer A.T., Fang A. The efficacy of cognitive behavioral therapy: a review of meta-analyses. Cognitive Therapy and Research 2012, 36:427-440.
29. Kazdin A.E. Understanding how and why psychotherapy leads to change. Psychotherapy Research 2009, 19:418-428.
30. Keehner M., Guerin S., Miller M., Turk D., Hegarty M. Modulation of neural activity by angle of rotation during imagined spatial transformations. Neuroimage 2006, 33:391-398.
31. Kircher T., Arolt V., Jansen A., Pyka M., Reinhardt I., Kellermann T., et al. Effect of cognitive-behavioral therapy on neural correlates of fear conditioning in panic disorder. Biological Psychiatry 2013, 73:93-101.
32. Kraemer H.C., Wilson G.T., Fairburn C.G., Agras W.S. Mediators and moderators of treatment effects in randomized clinical trials. Archives of General Psychiatry 2002, 59:877-883.
33. Lang T., Helbig-Lang S., Gloster A.T., Richter J., Hamm A.O., Fehm L., et al. Effects of therapist-guided exposure in CBT for panic disorder and agoraphobia. Zeitschrift fuer Klinische Psychologie und Psychotherapie 2012, 41:114-124.
34. Ledoux J.E., Iwata J., Cicchetti P., Reis D.J. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral-correlates of conditioned fear. Journal of Neuroscience 1988, 8:2517-2529.
35. Lee B.T., Ham B.J. Monoamine oxidase A-uVNTR genotype affects limbic brain activity in response to affective facial stimuli. Neuroreport 2008, 19:515-519.
36. Lissek S., Powers A.S., McClure E.B., Phelps E.A., Woldehawariat G., Grillon C., et al. Classical fear conditioning in the anxiety disorders: a meta-analysis. Behaviour Research and Therapy 2005, 43:1391-1424.
37. Lissek S., Rabin S.J., McDowell D.J., Dvir S., Bradford D.E., Geraci M., et al. Impaired discriminative fear-conditioning resulting from elevated fear responding to learned safety cues among individuals with panic disorder. Behaviour Research and Therapy 2009, 47:111-118.
38. Lueken U., Muehlhan M., Wittchen H.U., Kellermann T., Reinhardt I., Konrad C., et al. (Don't) panic in the scanner! How panic patients with agoraphobia experience a functional magnetic resonance imaging session. European neuropsychopharmacology 2011, 21:516-525.
39. Lueken U., Straube B., Konrad C., Wittchen H.U., Strohle A., Wittmann A., et al. Neural substrates of treatment response to cognitive-behavioral therapy in panic disorder with agoraphobia. The American Journal of Psychiatry 2013, 170:1344-1355.
40. Lueken U., Straube B., Reinhardt I., Maslowski N.I., Wittchen H.U., Strohle A., et al. Altered top-down and bottom-up processing of fear conditioning in panic disorder with agoraphobia. Psychological Medicine 2014, 44:381-394.
41. Lueken, U., Straube, B., Yang, Y., Beesdo-Baum, K., Konrad, C., Wittchen, H. U., etal. (in revision). Altered safety signal processing - A specific marker for panic disorder? The impact of comorbid depression on neural correlates of fear conditioning in panic disorder with agoraphobia.
42. Mantovani A., Aly M., Dagan Y., Allart A., Lisanby S.H. Randomized sham controlled trial of repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex for the treatment of panic disorder with comorbid major depression. Journal of Affective Disorders 2013, 144:153-159.
43. Maron E., Lang A., Tasa G., Liivlaid L., Toru I., Must A., et al. Associations between serotonin-related gene polymorphisms and panic disorder. International Journal of Neuropsychopharmacology 2005, 8:261-266.
44. Mathews A., MacLeod C. Cognitive vulnerability to emotional disorders. Annual Review of Clinical Psychology 2005, 1:167-195.
45. McHugh R.K., Smits J.A., Otto M.W. Empirically supported treatments for panic disorder. Psychiatry Clinics of North America 2009, 32:593-610.
46. McNaughton N., Corr P.J. Atwo-dimensional neuropsychology of defense: fear/anxiety and defensive distance. Neuroscience and Biobehavioral Reviews 2004, 28:285-305.
47. Messina I., Sambin M., Palmieri A., Viviani R. Neural correlates of psychotherapy in anxiety and depression: a meta-analysis. PLoS One 2013, 8:e74657.
48. Meuret A.E., Rosenfield D., Seidel A., Bhaskara L., Hofmann S.G. Respiratory and cognitive mediators of treatment change in panic disorder: evidence for intervention specificity. Journal of Consulting and Clinical Psychology 2010, 78:691-704.
49. Michael T., Blechert J., Vriends N., Margraf J., Wilhelm F.H. Fear conditioning in panic disorder: enhanced resistance to extinction. Journal of Abnormal Psychology 2007, 116:612-617.
50. Milad M.R., Quirk G.J. Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 2002, 420:70-74.
51. Moscovitch D.A., Antony M.M., Swinson R.P. Exposure-based treatments for anxiety disorders: theory and process. Oxford handbook of anxiety and related disorders 2009, 461-475. University Press, Oxford. M.M. Antony, M.B. Stein (Eds.).
52. Prasko J., Horacek J., Zalesky R., Kopecek M., Novak T., Paskova B., et al. The change of regional brain metabolism (18FDG PET) in panic disorder during the treatment with cognitive behavioral therapy or antidepressants. Neuro Endocrinology Letters 2004, 25:340-348.
53. Reif A., Richter J., Straube B., Hofler M., Lueken U., Gloster A.T., et al. MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy. Molecular Psychiatry 2014, 19:122-128.
54. Reinhardt I., Jansen A., Kellermann T., Schuppen A., Kohn N., Gerlach A.L., et al. Neural correlates of aversive conditioning: development of a functional imaging paradigm for the investigation of anxiety disorders. European Archives of Psychiatry and Clinical Neuroscience 2010, 260:443-453.
55. Ruiz S., Lee S., Soekadar S.R., Caria A., Veit R., Kircher T., et al. Acquired self-control of insula cortex modulates emotion recognition and brain network connectivity in schizophrenia. Human Brain Mapping 2013, 34:200-212.
56. Sabol S.Z., Hu S., Hamer D. Afunctional polymorphism in the monoamine oxidase A gene promoter. Human Genetics 1998, 103:273-279.
57. Sakai Y., Kumano H., Nishikawa M., Sakano Y., Kaiya H., Imabayashi E., et al. Changes in cerebral glucose utilization in patients with panic disorder treated with cognitive-behavioral therapy. Neuroimage 2006, 33:218-226.
58. Samochowiec J., Hajduk A., Samochowiec A., Horodnicki J., Stepien G., Grzywacz A., et al. Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum. Psychiatry Research 2004, 128:21-26.
59. Sanchez-Meca J., Rosa-Alcazar A.I., Marin-Martinez F., Gomez-Conesa A. Psychological treatment of panic disorder with or without agoraphobia: a meta-analysis. Clinical Psychology Review 2010, 30:37-50.
60. Schwartz J.M., Stoessel P.W., Baxter L.R., Martin K.M., Phelps M.E. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Archives of General Psychiatry 1996, 53:109-113.
61. Sehlmeyer C., Schoning S., Zwitserlood P., Pfleiderer B., Kircher T., Arolt V., et al. Human fear conditioning and extinction in neuroimaging: a systematic review. PLoS One 2009, 4:e5865.
62. Seo H.J., Choi Y.H., Chung Y.A., Rho W., Chae J.H. Changes in cerebral blood flow after cognitive behavior therapy in patients with panic disorder: a SPECT study. Neuropsychiatric Disease and Treatment 2014, 10:661-669.
63. Shin L.M., Liberzon I. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 2010, 35:169-191.
64. Shulman G.L., Ollinger J.M., Akbudak E., Conturo T.E., Snyder A.Z., Petersen S.E., et al. Areas involved in encoding and applying directional expectations to moving objects. Journal of Neuroscience 1999, 19:9480-9496.
65. Simon G.E., Perlis R.H. Personalized medicine for depression: can we match patients with treatments?. The American Journal of Psychiatry 2010, 167:1445-1455.
66. Stocker T., Schneider F., Klein M., Habel U., Kellermann T., Zilles K., Shah N.J. Automated quality assurance routines for fMRI data applied to a multicenter study. Human Brain Mapping 2005, 25:237-246.
67. Stewart R.E., Chambless D.L. Cognitive-behavioral therapy for adult anxiety disorders in clinical practice: a meta-analysis of effectiveness studies. Journal of Consulting and Clinical Psychology 2009, 77:595-606.
68. Straube B., Chatterjee A. Space and time in perceptual causality. Frontiers in Human Neuroscience 2010, 4:28.
69. Straube B., Lueken U., Jansen A., Konrad C., Gloster A.T., Gerlach A.L., et al. Neural correlates of procedural variants in cognitive behavioral therapy: a randomized, controlled multicentre fMRI study. Psychotherapy and Psychosomatics 2014, 83:222-233.
70. Thomaes K., Dorrepaal E., Draijer N., Jansma E.P., Veltman D.J., van Balkom A.J. Can pharmacological and psychological treatment change brain structure and function in PTSD? A systematic review. Journal of Psychiatric Research 2014, 50:1-15.
71. Weingarten C.P., Strauman T.J. Neuroimaging for psychotherapy research: current trends. Psychotherapy Research 2014, 10.1080/10503307.2014.883088.
72. Whisman M.A. Mediators and moderators of change in cognitive therapy of depression. Psychological Bulletin 1993, 114:248-265.